Study on the Construction and Application of Breastfeeding Behavior Intervention Program for Mothers of Infants With Congenital Heart Disease
Key facts
- Who runs it
- Children's Hospital of Fudan University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 68 people enrolled
- Started
- 25 Apr 2023
- Ended
- 30 May 2024
- Type of study
- Interventional, 2 groups
- Treatments tested
- Conventional care
- Breastfeeding behavioural intervention for mothers of infants with CHD
- Record updated
- 17 July 2024
Who can take part
- Age
- 1 day to 6 months
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- For infants; CHD was diagnosed within 14 days of birth; From birth to 14 days old; Exclusive breastfeeding or mixed feeding during enrollment
- For mothers; The mother is the primary caretaker for the infant with CHD; The mother has a smartphone and has the skills to use it; She has good reading and communication skills and can work fully with others; In good physical health with no clear disability, such as severe cardiovascular disease, etc; In good mental health, without any clearly diagnosed anxiety disorders, depression, etc; Mothers must be at least 18 years old
Who cannot take part
- For infants; Congenital anomalies such as gastrointestinal anomalies, facial anomalies, cleft lip and palate, and various syndromes due to chromosomal abnormalities are combined; Cardiac surgery was performed within 14 days of birth; The infant is not breastfed according to medical standards (for example, with galactosemia, phenylketonuria, or maple glycosuria)
- For mothers; Mothers with mental illness, cognitive impairment, etc. who struggle to communicate effectively; Those who have contraindications to breastfeeding, such as long-term use of specific types of drugs such as chemotherapy drugs, opioids, anti-epileptic drugs, anti-depressants, psychotropic drugs, etc; Systemic infectious diseases during feeding include HIV positive, active or untreated tuberculosis, recent syphilis infection, etc
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study is a randomized block trial designed to evaluate the effectiveness of a breastfeeding behavioural intervention program for mothers of infants with congenital heart disease (CHD). The purpose of this study is to compare exclusive breastfeeding rates, changes in weight-for-age z-scores (ΔWAZ) and height-for-age z-scores (ΔHAZ), and maternal breastfeeding behaviour between the intervention group and the control group at 1, 3, and 6 months of age.
The 2 groups in the trial
- Conventional care groupOther group
The management of infants with CHD and their mothers is based on the current breastfeeding process and care protocols at the Cardiovascular Centre of the Children's Hospital of Fudan University.
Treatment: Conventional care
- Breastfeeding intervention programTreatment being tested
Implement intervention programs to improve breastfeeding behaviour among mothers of infants with CHD and observe ongoing changes.
Treatment: Breastfeeding behavioural intervention for mothers of infants with CHD
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 17 July 2024